Li Auto heads into its third-quarter report with a recovery story that management has already put on paper and a stock that has refused to believe it. Last quarter the company argued that its painful product transition had bottomed: gross margin climbed back to 11.0% from 7.9%, operating cash flow returned to roughly breakeven, and guidance pointed higher. This report, due before the open on November 25, is the first real test of whether that sequential climb can keep going while the company absorbs rising component costs it has promised not to pass on to buyers.
Wall Street is looking for a loss of $0.08 per share on revenue of about $4.09 billion. That would be a modest step forward on both lines from a year ago, with revenue up roughly 6.4% and the loss slightly narrower than the $0.09 posted in the year-ago quarter. Sequentially the improvement looks larger, given the $0.25 loss and $3.78 billion in revenue last quarter. Management guided to $3.90 billion to $4.10 billion, equivalent to RMB26.6 billion to RMB28.0 billion on 95,000 to 100,000 deliveries. That guide landed well below the roughly $4.80 billion analysts had been modeling at the time, and consensus has since been cut back hard. The Street now sits essentially at the top of management's range, which means a merely in-line result could still read as a small disappointment. Hitting the upper end of the delivery band matters.
The composition of those deliveries may matter even more than the count. The quarter included the launch of the new-generation Li Mega in early September and the flagship i9 BEV SUV in mid-September, so only a few weeks of either vehicle's contribution will show up. More telling will be whether the refreshed L-series is holding its ground. Management said the L9 Livis was drawing an order mix of about 85% high-end trims and that the L6 was targeting a steady 10,000 units a month. Evidence that the richer mix is sticking would support the case that vehicle margin, which recovered to 9.4% from 6.1%, can keep rebuilding toward the company's newly framed healthy range of 15% to 20%. Investors should note that this target itself was a quiet step down from the roughly 20% gross margin Li Auto printed in late 2025.
That is where the raw-material issue becomes the swing factor. Management flagged inflation in batteries, memory chips and circuit boards as a fresh headwind and said it would eat the cost. In-house batteries now shipping on the L8, L6 and i8, with all models expected to follow within months, offer a partial offset, but the scale of that benefit has yet to show up in the numbers. A gross margin that stalls near 11% would suggest cost pressure is swallowing the mix gains; a move meaningfully higher would validate the recovery thesis. Cash is the other tell. The balance has fallen from RMB101.2 billion at the end of 2025 to RMB87.5 billion, partly from buybacks, and another quarter near breakeven operating cash flow would ease concern about the burn tied to heavy R&D.
Sentiment has softened from deeply bearish to modestly bearish, though the stock has not followed. Shares are down 4.7% since the last report, roughly in line with a weak market, and at $11.57 they trade well below the 200-day moving average of $14.55 and beneath last quarter's low. The stock sits in the lower half of its post-earnings range, so the market is clearly not pricing in a clean recovery.
The fourth-quarter outlook may ultimately carry the day. With a full quarter of the Mega and i9, European sales of the i6 and new overseas markets coming online, management's guide should show acceleration. If it pairs that with stable or rising margins despite cost inflation, the bottoming narrative holds. If not, the recovery looks more like a pause.